|
Author Question: Conclusions that are drawn during interviews that are not substantiated should be omitted. ... (Read 113 times) |
For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.
Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.
Approximately 25% of all reported medication errors result from some kind of name confusion.
The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.